Page last updated: 2024-10-25

dantrolene and Cortical Lewy Body Disease

dantrolene has been researched along with Cortical Lewy Body Disease in 1 studies

Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.

Research Excerpts

ExcerptRelevanceReference
" Thus, dantrolene administration was initiated with a tentative diagnosis of neuroleptic malignant syndrome (NMS)."3.91Neuroleptic malignant syndrome as part of an akinetic crisis associated with sepsis in a patient with Lewy body disease. ( Manabe, S; Ozawa, H; Takagi, A; Yanagi, H, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Manabe, S1
Yanagi, H1
Ozawa, H1
Takagi, A1

Other Studies

1 other study available for dantrolene and Cortical Lewy Body Disease

ArticleYear
Neuroleptic malignant syndrome as part of an akinetic crisis associated with sepsis in a patient with Lewy body disease.
    BMJ case reports, 2019, Feb-28, Volume: 12, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Dantrolene; Diagnosis, Differential; Female; Fluid Therapy; Humans; Lew

2019